

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.22730350 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.22730350 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.89660382 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.89660382 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.49829091 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 5.88589652 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 5.88589652 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.88589652 |
| 9 | kynurenine metabolic process (GO:0070189) | 5.72666859 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.60222390 |
| 11 | tryptophan metabolic process (GO:0006568) | 5.56170909 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.52885277 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.48479791 |
| 14 | negative regulation of fibrinolysis (GO:0051918) | 5.40569235 |
| 15 | cysteine metabolic process (GO:0006534) | 5.34953374 |
| 16 | urea cycle (GO:0000050) | 5.28049515 |
| 17 | urea metabolic process (GO:0019627) | 5.28049515 |
| 18 | regulation of protein activation cascade (GO:2000257) | 5.22300449 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.20919954 |
| 20 | protein carboxylation (GO:0018214) | 5.20919954 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.20692968 |
| 22 | regulation of fibrinolysis (GO:0051917) | 5.16872694 |
| 23 | complement activation, alternative pathway (GO:0006957) | 5.12446652 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 5.03875968 |
| 25 | high-density lipoprotein particle remodeling (GO:0034375) | 4.98926240 |
| 26 | regulation of complement activation (GO:0030449) | 4.91596787 |
| 27 | cell adhesion mediated by integrin (GO:0033627) | 4.87210010 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 4.83077353 |
| 29 | homocysteine metabolic process (GO:0050667) | 4.76759623 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 4.73046910 |
| 31 | bile acid metabolic process (GO:0008206) | 4.71171456 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.69587707 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 4.68796639 |
| 34 | lysine metabolic process (GO:0006553) | 4.63543313 |
| 35 | lysine catabolic process (GO:0006554) | 4.63543313 |
| 36 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.55080393 |
| 37 | Golgi transport vesicle coating (GO:0048200) | 4.51708868 |
| 38 | COPI coating of Golgi vesicle (GO:0048205) | 4.51708868 |
| 39 | tyrosine metabolic process (GO:0006570) | 4.50733380 |
| 40 | triglyceride homeostasis (GO:0070328) | 4.48772275 |
| 41 | acylglycerol homeostasis (GO:0055090) | 4.48772275 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.44161233 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.42778637 |
| 44 | desmosome organization (GO:0002934) | 4.41371213 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 4.37390610 |
| 46 | alpha-amino acid catabolic process (GO:1901606) | 4.32007417 |
| 47 | intestinal cholesterol absorption (GO:0030299) | 4.28828411 |
| 48 | cellular glucuronidation (GO:0052695) | 4.26139491 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.24168658 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.24168658 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.24168658 |
| 52 | regulation of cholesterol esterification (GO:0010872) | 4.21073442 |
| 53 | negative regulation of sterol transport (GO:0032372) | 4.16474160 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 4.16474160 |
| 55 | indolalkylamine metabolic process (GO:0006586) | 4.15162464 |
| 56 | fibrinolysis (GO:0042730) | 4.13129233 |
| 57 | plasma lipoprotein particle clearance (GO:0034381) | 4.12475957 |
| 58 | bile acid and bile salt transport (GO:0015721) | 4.12185432 |
| 59 | regulation of cholesterol homeostasis (GO:2000188) | 4.08179645 |
| 60 | glutamate metabolic process (GO:0006536) | 4.06554301 |
| 61 | phospholipid efflux (GO:0033700) | 4.05068305 |
| 62 | coenzyme catabolic process (GO:0009109) | 4.04795821 |
| 63 | regulation of bile acid biosynthetic process (GO:0070857) | 4.04407484 |
| 64 | cellular biogenic amine catabolic process (GO:0042402) | 4.01796672 |
| 65 | amine catabolic process (GO:0009310) | 4.01796672 |
| 66 | cellular amino acid catabolic process (GO:0009063) | 3.98435525 |
| 67 | cellular modified amino acid catabolic process (GO:0042219) | 3.98303467 |
| 68 | drug catabolic process (GO:0042737) | 3.96899518 |
| 69 | cellular ketone body metabolic process (GO:0046950) | 3.95371890 |
| 70 | benzene-containing compound metabolic process (GO:0042537) | 3.94943734 |
| 71 | serine family amino acid metabolic process (GO:0009069) | 3.89968147 |
| 72 | protein retention in ER lumen (GO:0006621) | 3.87091023 |
| 73 | cholesterol efflux (GO:0033344) | 3.87017988 |
| 74 | glycine metabolic process (GO:0006544) | 3.81683155 |
| 75 | glucuronate metabolic process (GO:0019585) | 3.79918518 |
| 76 | uronic acid metabolic process (GO:0006063) | 3.79918518 |
| 77 | imidazole-containing compound metabolic process (GO:0052803) | 3.75527830 |
| 78 | COPII vesicle coating (GO:0048208) | 3.74704696 |
| 79 | ethanol oxidation (GO:0006069) | 3.74698463 |
| 80 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.72212798 |
| 81 | urate metabolic process (GO:0046415) | 3.70448423 |
| 82 | drug transmembrane transport (GO:0006855) | 3.64117675 |
| 83 | arginine metabolic process (GO:0006525) | 3.64040322 |
| 84 | aldehyde catabolic process (GO:0046185) | 3.63550738 |
| 85 | negative regulation of lipase activity (GO:0060192) | 3.61195864 |
| 86 | phospholipid homeostasis (GO:0055091) | 3.60588947 |
| 87 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.59611137 |
| 88 | serine family amino acid biosynthetic process (GO:0009070) | 3.59601546 |
| 89 | plasma lipoprotein particle assembly (GO:0034377) | 3.58622910 |
| 90 | regulation of plasminogen activation (GO:0010755) | 3.58490933 |
| 91 | cholesterol homeostasis (GO:0042632) | 3.57197207 |
| 92 | negative regulation of protein activation cascade (GO:2000258) | 3.56361522 |
| 93 | positive regulation of lipid catabolic process (GO:0050996) | 3.55827293 |
| 94 | sterol homeostasis (GO:0055092) | 3.54075100 |
| 95 | exogenous drug catabolic process (GO:0042738) | 3.52404145 |
| 96 | acetyl-CoA metabolic process (GO:0006084) | 3.52208859 |
| 97 | complement activation, classical pathway (GO:0006958) | 3.51638816 |
| 98 | complement activation (GO:0006956) | 3.49457187 |
| 99 | positive regulation of extracellular matrix organization (GO:1903055) | 3.49089126 |
| 100 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.47754005 |
| 101 | organic acid catabolic process (GO:0016054) | 3.47303832 |
| 102 | carboxylic acid catabolic process (GO:0046395) | 3.47303832 |
| 103 | opsonization (GO:0008228) | 3.46793865 |
| 104 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.46703049 |
| 105 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.46703049 |
| 106 | protein activation cascade (GO:0072376) | 3.45142650 |
| 107 | cofactor catabolic process (GO:0051187) | 3.43855403 |
| 108 | protein hydroxylation (GO:0018126) | 3.43487392 |
| 109 | epoxygenase P450 pathway (GO:0019373) | 3.41834019 |
| 110 | short-chain fatty acid metabolic process (GO:0046459) | 3.41251666 |
| 111 | response to nitrosative stress (GO:0051409) | 3.40973347 |
| 112 | hemidesmosome assembly (GO:0031581) | 3.39958592 |
| 113 | mesodermal cell differentiation (GO:0048333) | 3.36706334 |
| 114 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.35909103 |
| 115 | negative regulation of complement activation (GO:0045916) | 3.13532875 |
| 116 | negative regulation of blood coagulation (GO:0030195) | 3.09568235 |
| 117 | negative regulation of hemostasis (GO:1900047) | 3.09568235 |
| 118 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.07571070 |
| 119 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.05933151 |
| 120 | regulation of apoptotic cell clearance (GO:2000425) | 3.03373603 |
| 121 | keratinocyte proliferation (GO:0043616) | 3.02660314 |
| 122 | negative regulation of coagulation (GO:0050819) | 3.02139388 |
| 123 | negative regulation of wound healing (GO:0061045) | 3.01778244 |
| 124 | peptidyl-proline hydroxylation (GO:0019511) | 3.01299770 |
| 125 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.97438408 |
| 126 | hypotonic response (GO:0006971) | 2.94339756 |
| 127 | regulation of metalloenzyme activity (GO:0048552) | 2.91995457 |
| 128 | * skin morphogenesis (GO:0043589) | 2.84208446 |
| 129 | protein-lipid complex assembly (GO:0065005) | 2.83874253 |
| 130 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.81765312 |
| 131 | positive regulation of blood coagulation (GO:0030194) | 2.81204858 |
| 132 | positive regulation of hemostasis (GO:1900048) | 2.81204858 |
| 133 | low-density lipoprotein particle clearance (GO:0034383) | 2.80654672 |
| 134 | muscle cell migration (GO:0014812) | 2.79639867 |
| 135 | negative regulation of fatty acid transport (GO:2000192) | 2.78887659 |
| 136 | vesicle coating (GO:0006901) | 2.75834417 |
| 137 | protein localization to endosome (GO:0036010) | 2.70327939 |
| 138 | 4-hydroxyproline metabolic process (GO:0019471) | 2.70029472 |
| 139 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.68852964 |
| 140 | endothelial cell morphogenesis (GO:0001886) | 2.68493219 |
| 141 | chondrocyte proliferation (GO:0035988) | 2.67934502 |
| 142 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.66629484 |
| 143 | blood coagulation, intrinsic pathway (GO:0007597) | 2.63363601 |
| 144 | positive regulation of coagulation (GO:0050820) | 2.62966352 |
| 145 | mammary gland epithelial cell proliferation (GO:0033598) | 2.59154406 |
| 146 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.58967528 |
| 147 | intestinal absorption (GO:0050892) | 2.57282927 |
| 148 | positive regulation of nuclease activity (GO:0032075) | 2.55974853 |
| 149 | phosphate ion transmembrane transport (GO:0035435) | 2.55176702 |
| 150 | protein maturation by protein folding (GO:0022417) | 2.52563820 |
| 151 | epithelial cell-cell adhesion (GO:0090136) | 2.52017473 |
| 152 | ER overload response (GO:0006983) | 2.51870677 |
| 153 | notochord development (GO:0030903) | 2.50609365 |
| 154 | positive regulation of osteoblast proliferation (GO:0033690) | 2.50407255 |
| 155 | basement membrane organization (GO:0071711) | 2.50193424 |
| 156 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.48552087 |
| 157 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.48523214 |
| 158 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.44896249 |
| 159 | cell-substrate junction assembly (GO:0007044) | 2.42567977 |
| 160 | ER-nucleus signaling pathway (GO:0006984) | 2.42027236 |
| 161 | gap junction assembly (GO:0016264) | 2.41940457 |
| 162 | lung lobe morphogenesis (GO:0060463) | 2.40494348 |
| 163 | bone remodeling (GO:0046849) | 2.39729374 |
| 164 | cellular copper ion homeostasis (GO:0006878) | 2.38586117 |
| 165 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.36890932 |
| 166 | cell proliferation involved in kidney development (GO:0072111) | 2.36890109 |
| 167 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.35131157 |
| 168 | acute-phase response (GO:0006953) | 2.34364086 |
| 169 | hepatocyte differentiation (GO:0070365) | 2.34140079 |
| 170 | cellular response to unfolded protein (GO:0034620) | 2.33634323 |
| 171 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.33365477 |
| 172 | surfactant homeostasis (GO:0043129) | 2.32588058 |
| 173 | regulation of extracellular matrix organization (GO:1903053) | 2.32226773 |
| 174 | endothelial cell chemotaxis (GO:0035767) | 2.31188492 |
| 175 | iron ion import (GO:0097286) | 2.31124737 |
| 176 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.31099658 |
| 177 | regulation of substrate adhesion-dependent cell spreading (GO:1900024) | 2.31079696 |
| 178 | hippo signaling (GO:0035329) | 2.30751814 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.61196031 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.47772403 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.04635975 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.93255243 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.82559494 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.26679159 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.25909715 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.93258237 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.26713255 |
| 10 | * AR_21909140_ChIP-Seq_LNCAP_Human | 2.50500716 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.35266119 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.20985402 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05019941 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.5821327 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.97884193 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.91522729 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.84638735 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.83653635 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.82020306 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.78148119 |
| 21 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.75756357 |
| 22 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.74493622 |
| 23 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.73070600 |
| 24 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.72333580 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.66194049 |
| 26 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.63209356 |
| 27 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.62252439 |
| 28 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.59237794 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.59123242 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57289477 |
| 31 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.56787770 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53492887 |
| 33 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.52049214 |
| 34 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.49609703 |
| 35 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.46438593 |
| 36 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.46276843 |
| 37 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.46116414 |
| 38 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.45734286 |
| 39 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.42412704 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37555393 |
| 41 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.34223980 |
| 42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.34192333 |
| 43 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.33242278 |
| 44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32385196 |
| 45 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.26294939 |
| 46 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.24937062 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22487619 |
| 48 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19586148 |
| 49 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.18358297 |
| 50 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17979902 |
| 51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17450959 |
| 52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16270928 |
| 53 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.16094424 |
| 54 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14775051 |
| 55 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.14617357 |
| 56 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.13756473 |
| 57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11689243 |
| 58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11689243 |
| 59 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.10746459 |
| 60 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.10277901 |
| 61 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06551451 |
| 62 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05590002 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.05386182 |
| 64 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03732196 |
| 65 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.03418702 |
| 66 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.02935992 |
| 67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00700754 |
| 68 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99492852 |
| 69 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98076397 |
| 70 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.96797482 |
| 71 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.96499465 |
| 72 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.95093244 |
| 73 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.94613093 |
| 74 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94013455 |
| 75 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 0.92841606 |
| 76 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92684873 |
| 77 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.92166921 |
| 78 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.91957038 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91142128 |
| 80 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90856676 |
| 81 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.90504336 |
| 82 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.89990553 |
| 83 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89581275 |
| 84 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.86548592 |
| 85 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.85190459 |
| 86 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.84395859 |
| 87 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80545940 |
| 88 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.80436525 |
| 89 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78632454 |
| 90 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.78092760 |
| 91 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76693006 |
| 92 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.74179275 |
| 93 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.70489904 |
| 94 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.70023040 |
| 95 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68029778 |
| 96 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.67991443 |
| 97 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.67018040 |
| 98 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66571815 |
| 99 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.65842430 |
| 100 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.65499606 |
| 101 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.63260890 |
| 102 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.63218669 |
| 103 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.60927689 |
| 104 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.60657969 |
| 105 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.59323797 |
| 106 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.59323797 |
| 107 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.59131598 |
| 108 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.57885429 |
| 109 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.57553791 |
| 110 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.56906100 |
| 111 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.56837152 |
| 112 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.56614853 |
| 113 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.56270707 |
| 114 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.55413990 |
| 115 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.55194335 |
| 116 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.54797011 |
| 117 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.53589640 |
| 118 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.53128078 |
| 119 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.52898366 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.52895186 |
| 121 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.50820661 |
| 122 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.50432945 |
| 123 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.50273153 |
| 124 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.49578647 |
| 125 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49318739 |
| 126 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.49253977 |
| 127 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.49223706 |
| 128 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.48833149 |
| 129 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.48523621 |
| 130 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.48404571 |
| 131 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.47955102 |
| 132 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.47955102 |
| 133 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.47919513 |
| 134 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.47373777 |
| 135 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.47370079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.76293941 |
| 2 | MP0005360_urolithiasis | 7.15914875 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.00472325 |
| 4 | MP0005365_abnormal_bile_salt | 5.70055051 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.83877624 |
| 6 | MP0003252_abnormal_bile_duct | 3.90288530 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.59613938 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.28050409 |
| 9 | MP0003950_abnormal_plasma_membrane | 3.14508921 |
| 10 | MP0005083_abnormal_biliary_tract | 3.03419824 |
| 11 | MP0003195_calcinosis | 2.96602463 |
| 12 | MP0009840_abnormal_foam_cell | 2.94351824 |
| 13 | MP0005332_abnormal_amino_acid | 2.74750756 |
| 14 | MP0005257_abnormal_intraocular_pressure | 2.68728596 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.46915961 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.31929828 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 2.27598290 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.27446912 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.19495023 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 2.18185906 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.16441101 |
| 22 | MP0000609_abnormal_liver_physiology | 2.05765676 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.98991946 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 1.83255198 |
| 25 | MP0005076_abnormal_cell_differentiation | 1.74822914 |
| 26 | MP0003941_abnormal_skin_development | 1.73507577 |
| 27 | MP0003123_paternal_imprinting | 1.73283485 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 1.71743240 |
| 29 | MP0003868_abnormal_feces_composition | 1.70680388 |
| 30 | MP0000762_abnormal_tongue_morphology | 1.57888557 |
| 31 | MP0000566_synostosis | 1.52700358 |
| 32 | MP0003091_abnormal_cell_migration | 1.48714716 |
| 33 | MP0005623_abnormal_meninges_morphology | 1.48414271 |
| 34 | MP0000003_abnormal_adipose_tissue | 1.46023619 |
| 35 | MP0010030_abnormal_orbit_morphology | 1.42576260 |
| 36 | MP0004185_abnormal_adipocyte_glucose | 1.41015266 |
| 37 | MP0009643_abnormal_urine_homeostasis | 1.40143857 |
| 38 | MP0002254_reproductive_system_inflammat | 1.39932194 |
| 39 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.38436044 |
| 40 | MP0001764_abnormal_homeostasis | 1.31624216 |
| 41 | MP0004233_abnormal_muscle_weight | 1.30843043 |
| 42 | MP0010368_abnormal_lymphatic_system | 1.30627350 |
| 43 | MP0009697_abnormal_copulation | 1.28431004 |
| 44 | MP0005409_darkened_coat_color | 1.28346982 |
| 45 | MP0005451_abnormal_body_composition | 1.26146490 |
| 46 | MP0003011_delayed_dark_adaptation | 1.24414883 |
| 47 | MP0001915_intracranial_hemorrhage | 1.22285689 |
| 48 | MP0005375_adipose_tissue_phenotype | 1.18205355 |
| 49 | MP0000537_abnormal_urethra_morphology | 1.16583835 |
| 50 | MP0010678_abnormal_skin_adnexa | 1.15249364 |
| 51 | MP0001299_abnormal_eye_distance/ | 1.14515755 |
| 52 | MP0005501_abnormal_skin_physiology | 1.12845935 |
| 53 | MP0000598_abnormal_liver_morphology | 1.12592046 |
| 54 | MP0003186_abnormal_redox_activity | 1.11835021 |
| 55 | MP0002089_abnormal_postnatal_growth/wei | 1.05185537 |
| 56 | MP0009764_decreased_sensitivity_to | 1.03350914 |
| 57 | MP0000013_abnormal_adipose_tissue | 1.01911957 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.01664882 |
| 59 | MP0001879_abnormal_lymphatic_vessel | 1.01602494 |
| 60 | MP0003315_abnormal_perineum_morphology | 1.01338813 |
| 61 | MP0000627_abnormal_mammary_gland | 0.99575336 |
| 62 | MP0005197_abnormal_uvea_morphology | 0.99314831 |
| 63 | MP0005636_abnormal_mineral_homeostasis | 0.99117558 |
| 64 | MP0000767_abnormal_smooth_muscle | 0.98994645 |
| 65 | MP0005647_abnormal_sex_gland | 0.95436615 |
| 66 | MP0000604_amyloidosis | 0.94409226 |
| 67 | * MP0001216_abnormal_epidermal_layer | 0.93979333 |
| 68 | MP0009763_increased_sensitivity_to | 0.93382598 |
| 69 | MP0008438_abnormal_cutaneous_collagen | 0.93208317 |
| 70 | MP0002697_abnormal_eye_size | 0.89400151 |
| 71 | MP0005220_abnormal_exocrine_pancreas | 0.88892747 |
| 72 | MP0003115_abnormal_respiratory_system | 0.87176864 |
| 73 | MP0009384_cardiac_valve_regurgitation | 0.86589739 |
| 74 | MP0000858_altered_metastatic_potential | 0.84980383 |
| 75 | MP0000751_myopathy | 0.84972015 |
| 76 | MP0002086_abnormal_extraembryonic_tissu | 0.84739743 |
| 77 | MP0005670_abnormal_white_adipose | 0.84048609 |
| 78 | MP0000467_abnormal_esophagus_morphology | 0.83567572 |
| 79 | MP0005165_increased_susceptibility_to | 0.82447493 |
| 80 | MP0005408_hypopigmentation | 0.81597920 |
| 81 | MP0003943_abnormal_hepatobiliary_system | 0.80524856 |
| 82 | MP0005084_abnormal_gallbladder_morpholo | 0.80441524 |
| 83 | MP0009053_abnormal_anal_canal | 0.79768328 |
| 84 | MP0000534_abnormal_ureter_morphology | 0.79579071 |
| 85 | MP0006054_spinal_hemorrhage | 0.78657103 |
| 86 | MP0008469_abnormal_protein_level | 0.78596369 |
| 87 | MP0009642_abnormal_blood_homeostasis | 0.78381496 |
| 88 | MP0001756_abnormal_urination | 0.78123951 |
| 89 | MP0003942_abnormal_urinary_system | 0.77271009 |
| 90 | MP0010771_integument_phenotype | 0.75603920 |
| 91 | MP0004858_abnormal_nervous_system | 0.75190558 |
| 92 | MP0003385_abnormal_body_wall | 0.74558604 |
| 93 | MP0002971_abnormal_brown_adipose | 0.73312895 |
| 94 | MP0002060_abnormal_skin_morphology | 0.72518397 |
| 95 | MP0004782_abnormal_surfactant_physiolog | 0.72154053 |
| 96 | MP0003890_abnormal_embryonic-extraembry | 0.72029021 |
| 97 | MP0005376_homeostasis/metabolism_phenot | 0.70719874 |
| 98 | MP0005275_abnormal_skin_tensile | 0.70325453 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.68041765 |
| 100 | MP0002078_abnormal_glucose_homeostasis | 0.67574946 |
| 101 | MP0005193_abnormal_anterior_eye | 0.67484382 |
| 102 | MP0005023_abnormal_wound_healing | 0.67443257 |
| 103 | MP0003724_increased_susceptibility_to | 0.67145460 |
| 104 | MP0002168_other_aberrant_phenotype | 0.67062117 |
| 105 | MP0001730_embryonic_growth_arrest | 0.66293201 |
| 106 | MP0005621_abnormal_cell_physiology | 0.66044019 |
| 107 | MP0009765_abnormal_xenobiotic_induced | 0.65552993 |
| 108 | * MP0001614_abnormal_blood_vessel | 0.64395490 |
| 109 | * MP0001340_abnormal_eyelid_morphology | 0.63670430 |
| 110 | MP0001661_extended_life_span | 0.63306799 |
| 111 | MP0005508_abnormal_skeleton_morphology | 0.63072941 |
| 112 | MP0005334_abnormal_fat_pad | 0.62504590 |
| 113 | MP0000733_abnormal_muscle_development | 0.62317043 |
| 114 | MP0003300_gastrointestinal_ulcer | 0.62105438 |
| 115 | MP0002928_abnormal_bile_duct | 0.61896572 |
| 116 | MP0002098_abnormal_vibrissa_morphology | 0.61659504 |
| 117 | MP0005395_other_phenotype | 0.61449129 |
| 118 | MP0004197_abnormal_fetal_growth/weight/ | 0.61398868 |
| 119 | MP0000383_abnormal_hair_follicle | 0.61349067 |
| 120 | MP0002796_impaired_skin_barrier | 0.59512585 |
| 121 | MP0010234_abnormal_vibrissa_follicle | 0.59351984 |
| 122 | MP0005248_abnormal_Harderian_gland | 0.58852070 |
| 123 | MP0005666_abnormal_adipose_tissue | 0.58223046 |
| 124 | MP0004130_abnormal_muscle_cell | 0.57719284 |
| 125 | MP0005164_abnormal_response_to | 0.55247282 |
| 126 | MP0002295_abnormal_pulmonary_circulatio | 0.54325713 |
| 127 | MP0001243_abnormal_dermal_layer | 0.52858675 |
| 128 | MP0000639_abnormal_adrenal_gland | 0.52773399 |
| 129 | MP0003453_abnormal_keratinocyte_physiol | 0.52092440 |
| 130 | MP0004883_abnormal_blood_vessel | 0.51107730 |
| 131 | MP0003329_amyloid_beta_deposits | 0.51026424 |
| 132 | MP0001881_abnormal_mammary_gland | 0.50666205 |
| 133 | MP0005166_decreased_susceptibility_to | 0.50453665 |
| 134 | MP0000579_abnormal_nail_morphology | 0.50252708 |
| 135 | MP0003690_abnormal_glial_cell | 0.48712012 |
| 136 | MP0002876_abnormal_thyroid_physiology | 0.48182206 |
| 137 | MP0005535_abnormal_body_temperature | 0.47959267 |
| 138 | MP0004264_abnormal_extraembryonic_tissu | 0.46799188 |
| 139 | MP0004272_abnormal_basement_membrane | 0.46715037 |
| 140 | MP0003638_abnormal_response/metabolism_ | 0.46515848 |
| 141 | MP0002896_abnormal_bone_mineralization | 0.45860417 |
| 142 | MP0002282_abnormal_trachea_morphology | 0.45095115 |
| 143 | MP0003075_altered_response_to | 0.44380812 |
| 144 | MP0003436_decreased_susceptibility_to | 0.43511708 |
| 145 | MP0003566_abnormal_cell_adhesion | 0.43087319 |
| 146 | MP0001765_abnormal_ion_homeostasis | 0.42890323 |
| 147 | MP0006036_abnormal_mitochondrial_physio | 0.42277320 |
| 148 | MP0000249_abnormal_blood_vessel | 0.42090461 |
| 149 | MP0005448_abnormal_energy_balance | 0.42077392 |
| 150 | MP0000230_abnormal_systemic_arterial | 0.41180224 |
| 151 | MP0005266_abnormal_metabolism | 0.40513089 |
| 152 | MP0000427_abnormal_hair_cycle | 0.39982688 |
| 153 | MP0001958_emphysema | 0.37950789 |
| 154 | MP0004043_abnormal_pH_regulation | 0.35687299 |
| 155 | MP0001542_abnormal_bone_strength | 0.35681340 |
| 156 | MP0005595_abnormal_vascular_smooth | 0.35431568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.00754765 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.92067297 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.88469042 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.30190430 |
| 5 | Xanthomatosis (HP:0000991) | 6.29542507 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.81787510 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.66655841 |
| 8 | Complement deficiency (HP:0004431) | 5.20073830 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.97340441 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.51285601 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.42055159 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.41492495 |
| 13 | Joint hemorrhage (HP:0005261) | 4.33266771 |
| 14 | Epidermoid cyst (HP:0200040) | 4.29321967 |
| 15 | Premature rupture of membranes (HP:0001788) | 4.28861684 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.21005288 |
| 17 | Hyperammonemia (HP:0001987) | 4.15864913 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.10645965 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.97883565 |
| 20 | Ketosis (HP:0001946) | 3.96911041 |
| 21 | Abnormality of complement system (HP:0005339) | 3.94667589 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.93942264 |
| 23 | Hyperglycinemia (HP:0002154) | 3.85794567 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.85713417 |
| 25 | Fat malabsorption (HP:0002630) | 3.83830714 |
| 26 | Protrusio acetabuli (HP:0003179) | 3.75410929 |
| 27 | Abnormality of the intrinsic pathway (HP:0010989) | 3.66351733 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.63840228 |
| 29 | Hyperglycinuria (HP:0003108) | 3.63004847 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.57220154 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.57220154 |
| 32 | Right ventricular cardiomyopathy (HP:0011663) | 3.51208694 |
| 33 | Myocardial infarction (HP:0001658) | 3.37641157 |
| 34 | Arterial tortuosity (HP:0005116) | 3.36652546 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.31594087 |
| 36 | Gout (HP:0001997) | 3.28255162 |
| 37 | Hypercholesterolemia (HP:0003124) | 3.22773667 |
| 38 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.18421042 |
| 39 | Hepatocellular carcinoma (HP:0001402) | 3.09221634 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.08693788 |
| 41 | Abnormality of purine metabolism (HP:0004352) | 3.03830162 |
| 42 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.01378955 |
| 43 | Vascular calcification (HP:0004934) | 3.00003904 |
| 44 | Spontaneous abortion (HP:0005268) | 2.98846683 |
| 45 | Vascular tortuosity (HP:0004948) | 2.97106612 |
| 46 | Ketoacidosis (HP:0001993) | 2.90359002 |
| 47 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.90211268 |
| 48 | Abnormality of carpal bone ossification (HP:0006257) | 2.87712151 |
| 49 | Hyperbilirubinemia (HP:0002904) | 2.86303230 |
| 50 | Short nail (HP:0001799) | 2.83467212 |
| 51 | Steatorrhea (HP:0002570) | 2.83212743 |
| 52 | Cardiovascular calcification (HP:0011915) | 2.81269956 |
| 53 | Skin nodule (HP:0200036) | 2.79972709 |
| 54 | Delayed CNS myelination (HP:0002188) | 2.75170648 |
| 55 | Flat acetabular roof (HP:0003180) | 2.72300213 |
| 56 | Upper limb muscle weakness (HP:0003484) | 2.67687765 |
| 57 | Systemic lupus erythematosus (HP:0002725) | 2.64757733 |
| 58 | Mitral stenosis (HP:0001718) | 2.64543464 |
| 59 | Abnormality of serum amino acid levels (HP:0003112) | 2.61967473 |
| 60 | Small epiphyses (HP:0010585) | 2.61590421 |
| 61 | Cervical subluxation (HP:0003308) | 2.59959251 |
| 62 | Aortic dissection (HP:0002647) | 2.59052681 |
| 63 | Vertebral compression fractures (HP:0002953) | 2.57103699 |
| 64 | Atrophic scars (HP:0001075) | 2.51309515 |
| 65 | Esophageal varix (HP:0002040) | 2.45589168 |
| 66 | Malnutrition (HP:0004395) | 2.44680678 |
| 67 | Metabolic acidosis (HP:0001942) | 2.42539074 |
| 68 | Spastic diplegia (HP:0001264) | 2.42171008 |
| 69 | Hypoglycemic seizures (HP:0002173) | 2.36984818 |
| 70 | Hydroxyprolinuria (HP:0003080) | 2.36484317 |
| 71 | Abnormality of proline metabolism (HP:0010907) | 2.36484317 |
| 72 | Hypochromic microcytic anemia (HP:0004840) | 2.34766527 |
| 73 | Abnormal ossification of hand bones (HP:0005921) | 2.33877474 |
| 74 | Abnormal cartilage morphology (HP:0002763) | 2.29436144 |
| 75 | Glomerulonephritis (HP:0000099) | 2.26264856 |
| 76 | Sensorimotor neuropathy (HP:0007141) | 2.25296478 |
| 77 | Amyloidosis (HP:0011034) | 2.24705454 |
| 78 | Enlarged kidneys (HP:0000105) | 2.24691989 |
| 79 | Pterygium (HP:0001059) | 2.23426395 |
| 80 | Abnormal gallbladder morphology (HP:0012437) | 2.23001155 |
| 81 | Cholecystitis (HP:0001082) | 2.22308711 |
| 82 | Abnormal gallbladder physiology (HP:0012438) | 2.22308711 |
| 83 | Hyperuricemia (HP:0002149) | 2.20865406 |
| 84 | Increased purine levels (HP:0004368) | 2.20865406 |
| 85 | Lethargy (HP:0001254) | 2.20455175 |
| 86 | Asymmetry of the thorax (HP:0001555) | 2.18465213 |
| 87 | Focal segmental glomerulosclerosis (HP:0000097) | 2.17562437 |
| 88 | Rickets (HP:0002748) | 2.15931957 |
| 89 | Dicarboxylic aciduria (HP:0003215) | 2.15512063 |
| 90 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.15512063 |
| 91 | Neonatal onset (HP:0003623) | 2.15493235 |
| 92 | Cholelithiasis (HP:0001081) | 2.14730745 |
| 93 | Acanthocytosis (HP:0001927) | 2.14390386 |
| 94 | Irritability (HP:0000737) | 2.13726450 |
| 95 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.13656233 |
| 96 | Osteolytic defects of the hand bones (HP:0009699) | 2.13656233 |
| 97 | Abnormal hand bone ossification (HP:0010660) | 2.12912446 |
| 98 | Protuberant abdomen (HP:0001538) | 2.10452064 |
| 99 | Abnormal tarsal ossification (HP:0008369) | 2.09919014 |
| 100 | Menorrhagia (HP:0000132) | 2.09286346 |
| 101 | Follicular hyperkeratosis (HP:0007502) | 2.08285279 |
| 102 | Abnormal delivery (HP:0001787) | 2.07149670 |
| 103 | Wormian bones (HP:0002645) | 2.05111408 |
| 104 | Abnormality of the acetabulum (HP:0003170) | 2.04993558 |
| 105 | Glomerulosclerosis (HP:0000096) | 2.04813529 |
| 106 | Late onset (HP:0003584) | 2.04568230 |
| 107 | Gingival bleeding (HP:0000225) | 2.04249680 |
| 108 | Hypophosphatemic rickets (HP:0004912) | 2.02818981 |
| 109 | Alkalosis (HP:0001948) | 2.00603728 |
| 110 | Pancreatitis (HP:0001733) | 2.00590678 |
| 111 | Abnormality of the nasal septum (HP:0000419) | 1.97127585 |
| 112 | Fragile skin (HP:0001030) | 1.96530422 |
| 113 | Hemorrhage of the eye (HP:0011885) | 1.96076226 |
| 114 | Generalized aminoaciduria (HP:0002909) | 1.95874349 |
| 115 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.95571367 |
| 116 | Bronchomalacia (HP:0002780) | 1.94923914 |
| 117 | Hyperglycemia (HP:0003074) | 1.94451015 |
| 118 | Achilles tendon contracture (HP:0001771) | 1.92172494 |
| 119 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.91627056 |
| 120 | Alopecia of scalp (HP:0002293) | 1.91338847 |
| 121 | Cerebral aneurysm (HP:0004944) | 1.90415180 |
| 122 | Proximal tubulopathy (HP:0000114) | 1.89967675 |
| 123 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.89943267 |
| 124 | Thrombophlebitis (HP:0004418) | 1.89819592 |
| 125 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.89392298 |
| 126 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.87132505 |
| 127 | Advanced eruption of teeth (HP:0006288) | 1.85699740 |
| 128 | Natal tooth (HP:0000695) | 1.85110869 |
| 129 | Shallow orbits (HP:0000586) | 1.84563320 |
| 130 | Microglossia (HP:0000171) | 1.83390661 |
| 131 | Spinal rigidity (HP:0003306) | 1.83310217 |
| 132 | Vomiting (HP:0002013) | 1.82647643 |
| 133 | Coxa vara (HP:0002812) | 1.82114626 |
| 134 | Back pain (HP:0003418) | 1.81781033 |
| 135 | Nephritis (HP:0000123) | 1.81610610 |
| 136 | Vitreoretinal degeneration (HP:0000655) | 1.79581586 |
| 137 | Abnormality of the gallbladder (HP:0005264) | 1.79075722 |
| 138 | Broad face (HP:0000283) | 1.78694220 |
| 139 | Vertebral arch anomaly (HP:0008438) | 1.77849720 |
| 140 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.77128415 |
| 141 | Cerebral edema (HP:0002181) | 1.77072451 |
| 142 | Abnormality of iron homeostasis (HP:0011031) | 1.74974911 |
| 143 | Aortic aneurysm (HP:0004942) | 1.73642889 |
| 144 | Abnormality of dentin (HP:0010299) | 1.73497670 |
| 145 | Blue sclerae (HP:0000592) | 1.73030002 |
| 146 | Abnormality of the Achilles tendon (HP:0005109) | 1.72536796 |
| 147 | Abnormality of the gastric mucosa (HP:0004295) | 1.72061387 |
| 148 | Distal upper limb amyotrophy (HP:0007149) | 1.71299405 |
| 149 | Upper limb amyotrophy (HP:0009129) | 1.71299405 |
| 150 | Neonatal death (HP:0003811) | 1.70782268 |
| 151 | Acanthosis nigricans (HP:0000956) | 1.70404514 |
| 152 | Abnormal foot bone ossification (HP:0010675) | 1.69123520 |
| 153 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.69003444 |
| 154 | Ankle contracture (HP:0006466) | 1.67994979 |
| 155 | Deviation of the thumb (HP:0009603) | 1.67904585 |
| 156 | Protruding ear (HP:0000411) | 1.67641516 |
| 157 | Spinal cord compression (HP:0002176) | 1.67625752 |
| 158 | Limited elbow extension (HP:0001377) | 1.66961320 |
| 159 | Subacute progressive viral hepatitis (HP:0006572) | 1.64280125 |
| 160 | Thin skin (HP:0000963) | 1.62020168 |
| 161 | Abnormality of glycolysis (HP:0004366) | 1.61246796 |
| 162 | Renal duplication (HP:0000075) | 1.60855457 |
| 163 | Insomnia (HP:0100785) | 1.60047885 |
| 164 | Soft skin (HP:0000977) | 1.59903686 |
| 165 | Popliteal pterygium (HP:0009756) | 1.59416095 |
| 166 | Neonatal short-limb short stature (HP:0008921) | 1.58989818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 4.68655657 |
| 2 | BCKDK | 4.64641646 |
| 3 | ERN1 | 4.06170213 |
| 4 | SIK1 | 3.85839613 |
| 5 | LATS1 | 3.03171648 |
| 6 | ERBB4 | 3.02767443 |
| 7 | EPHA2 | 2.69364107 |
| 8 | MAP3K3 | 2.57940156 |
| 9 | MST1R | 2.54028874 |
| 10 | TAOK3 | 2.43137810 |
| 11 | LMTK2 | 2.25798983 |
| 12 | EPHB1 | 2.18448489 |
| 13 | INSRR | 2.10997492 |
| 14 | TRIB3 | 2.08692862 |
| 15 | MST4 | 2.02403323 |
| 16 | EPHA3 | 1.95296255 |
| 17 | IRAK3 | 1.93663979 |
| 18 | ICK | 1.87371370 |
| 19 | PAK4 | 1.81527916 |
| 20 | STK38L | 1.79018135 |
| 21 | PTK6 | 1.67547813 |
| 22 | FRK | 1.62912080 |
| 23 | FGFR2 | 1.62312314 |
| 24 | NEK9 | 1.61302312 |
| 25 | TESK1 | 1.57433179 |
| 26 | PKN2 | 1.56333313 |
| 27 | MET | 1.56028994 |
| 28 | PIK3CG | 1.50957038 |
| 29 | MAPK15 | 1.47459311 |
| 30 | RIPK1 | 1.47255403 |
| 31 | CDK12 | 1.40524619 |
| 32 | STK39 | 1.37090651 |
| 33 | NTRK1 | 1.34445294 |
| 34 | MAP2K4 | 1.32642055 |
| 35 | MAPK11 | 1.30749443 |
| 36 | LIMK1 | 1.27672813 |
| 37 | EIF2AK1 | 1.25481967 |
| 38 | PTK2 | 1.22517487 |
| 39 | ABL2 | 1.20556897 |
| 40 | NME2 | 1.20438511 |
| 41 | MAP3K12 | 1.18572119 |
| 42 | PBK | 1.17996546 |
| 43 | STK24 | 1.17289739 |
| 44 | SCYL2 | 1.16526255 |
| 45 | TGFBR2 | 1.15713853 |
| 46 | STK38 | 1.13245316 |
| 47 | MAP3K9 | 1.11738918 |
| 48 | AKT3 | 1.11261114 |
| 49 | GSK3A | 1.11087974 |
| 50 | FLT3 | 1.08125855 |
| 51 | FER | 1.04292377 |
| 52 | DDR2 | 1.03986464 |
| 53 | MAP3K7 | 1.00698728 |
| 54 | TYK2 | 0.99392595 |
| 55 | MAP2K3 | 0.97859881 |
| 56 | ERBB2 | 0.97299924 |
| 57 | BCR | 0.96437576 |
| 58 | WNK4 | 0.95535176 |
| 59 | TBK1 | 0.95460557 |
| 60 | PRKAA2 | 0.95227209 |
| 61 | JAK2 | 0.94578833 |
| 62 | JAK1 | 0.93275548 |
| 63 | EIF2AK3 | 0.92568509 |
| 64 | WNK1 | 0.91724773 |
| 65 | CDK6 | 0.90248552 |
| 66 | KDR | 0.89061709 |
| 67 | SIK3 | 0.89022553 |
| 68 | DAPK2 | 0.88633060 |
| 69 | NEK1 | 0.86142829 |
| 70 | FGFR3 | 0.86071954 |
| 71 | MAP3K14 | 0.83779302 |
| 72 | STK10 | 0.82010630 |
| 73 | STK3 | 0.81999232 |
| 74 | PDGFRA | 0.77113032 |
| 75 | BMX | 0.75131620 |
| 76 | ARAF | 0.73796256 |
| 77 | CDK8 | 0.73440748 |
| 78 | MAP3K11 | 0.72781832 |
| 79 | MAP3K2 | 0.72355423 |
| 80 | MAPK4 | 0.72087001 |
| 81 | DYRK1B | 0.70096308 |
| 82 | LATS2 | 0.69417149 |
| 83 | TRIM28 | 0.68699682 |
| 84 | BUB1 | 0.67857384 |
| 85 | TRPM7 | 0.67075358 |
| 86 | TIE1 | 0.66936244 |
| 87 | BRSK1 | 0.66553809 |
| 88 | ERBB3 | 0.64906505 |
| 89 | MTOR | 0.64856531 |
| 90 | CSK | 0.63406946 |
| 91 | BRSK2 | 0.63175556 |
| 92 | DMPK | 0.63167737 |
| 93 | MELK | 0.62495657 |
| 94 | EPHB2 | 0.61419277 |
| 95 | CAMK2G | 0.61024983 |
| 96 | MAP2K1 | 0.60619568 |
| 97 | CAMK1D | 0.58128793 |
| 98 | SGK3 | 0.56882712 |
| 99 | MYLK | 0.56468680 |
| 100 | MAP3K1 | 0.55351927 |
| 101 | PRKCZ | 0.55217497 |
| 102 | NUAK1 | 0.54833541 |
| 103 | IRAK1 | 0.54705596 |
| 104 | TTN | 0.54425866 |
| 105 | MAP3K10 | 0.52938780 |
| 106 | MAPK12 | 0.52160986 |
| 107 | PAK2 | 0.51306230 |
| 108 | TSSK6 | 0.49581400 |
| 109 | PRKACG | 0.48563139 |
| 110 | MAP2K2 | 0.47917187 |
| 111 | OXSR1 | 0.47854437 |
| 112 | CDK9 | 0.47743780 |
| 113 | PIK3CA | 0.46567404 |
| 114 | FGFR1 | 0.46503507 |
| 115 | MAPK7 | 0.46476460 |
| 116 | SGK223 | 0.46080583 |
| 117 | SGK494 | 0.46080583 |
| 118 | PRKG2 | 0.46046903 |
| 119 | WNK3 | 0.45585525 |
| 120 | RET | 0.45033352 |
| 121 | PRKAA1 | 0.44948179 |
| 122 | NEK2 | 0.44192708 |
| 123 | PAK3 | 0.43933850 |
| 124 | IGF1R | 0.42749229 |
| 125 | PDK2 | 0.41805609 |
| 126 | PIM2 | 0.41738598 |
| 127 | NLK | 0.41613255 |
| 128 | PINK1 | 0.41302365 |
| 129 | PDPK1 | 0.41195916 |
| 130 | EGFR | 0.40375780 |
| 131 | ILK | 0.40257920 |
| 132 | MAP3K5 | 0.39195583 |
| 133 | MOS | 0.39089295 |
| 134 | PDGFRB | 0.38439160 |
| 135 | SMG1 | 0.36572280 |
| 136 | TAOK2 | 0.36309304 |
| 137 | EIF2AK2 | 0.35613708 |
| 138 | CHUK | 0.35450768 |
| 139 | ABL1 | 0.35371571 |
| 140 | MAPKAPK3 | 0.34332575 |
| 141 | MAP3K6 | 0.33696217 |
| 142 | YES1 | 0.33511817 |
| 143 | CDK7 | 0.33331162 |
| 144 | SGK2 | 0.33313095 |
| 145 | TAOK1 | 0.33258210 |
| 146 | IKBKE | 0.32916026 |
| 147 | PRKCI | 0.29108708 |
| 148 | EEF2K | 0.28846899 |
| 149 | ROCK2 | 0.28728952 |
| 150 | CDC42BPA | 0.28640033 |
| 151 | KSR1 | 0.27975305 |
| 152 | AKT2 | 0.27881916 |
| 153 | MAP3K8 | 0.27763298 |
| 154 | MAPKAPK2 | 0.26781067 |
| 155 | TTK | 0.26359257 |
| 156 | BRD4 | 0.25652203 |
| 157 | BRAF | 0.24749367 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.38318909 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.72569653 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.41665521 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.34009593 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.01547116 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.82697190 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69457800 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.56510372 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.50264210 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.44125490 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43439520 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31406795 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.29029328 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12000782 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.08746813 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.04270197 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91256547 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90283299 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88338352 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.84283163 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.84192177 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.83623537 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79462423 |
| 24 | Adherens junction_Homo sapiens_hsa04520 | 1.79204638 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73925484 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72937767 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67868578 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64801005 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64012800 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62811915 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.58334781 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.57010020 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.55911586 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54952858 |
| 35 | Circadian rhythm_Homo sapiens_hsa04710 | 1.53168056 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.49969257 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.48415121 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.41130446 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38131848 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34920963 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31767444 |
| 42 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.31276377 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.30800955 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23659902 |
| 45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.22713237 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19995021 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19324629 |
| 48 | Thyroid cancer_Homo sapiens_hsa05216 | 1.18410919 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16191864 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.13966901 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.13477727 |
| 52 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.12641598 |
| 53 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.11189483 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10784945 |
| 55 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.10724064 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09427060 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 1.03504415 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.02694429 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02028924 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01145180 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99954057 |
| 62 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.99248425 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97911618 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.86464356 |
| 65 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86307305 |
| 66 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.84218538 |
| 67 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.79984200 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77662423 |
| 69 | Tight junction_Homo sapiens_hsa04530 | 0.77007178 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75101687 |
| 71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74175381 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73467066 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73028750 |
| 74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70872665 |
| 75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68952281 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66213231 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64981200 |
| 78 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.62957465 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62402815 |
| 80 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.62155797 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58943743 |
| 82 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.58682677 |
| 83 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58153451 |
| 84 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56355373 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54086522 |
| 86 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53738410 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51366173 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50222927 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47985324 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47197469 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45435124 |
| 92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44746071 |
| 93 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.43962613 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.41833346 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41168547 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.40939866 |
| 97 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.39472919 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37810472 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.35421921 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34542856 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24459624 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22463137 |
| 103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.19511713 |
| 104 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17954535 |
| 105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14374325 |
| 106 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.14285688 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12830614 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10757236 |
| 109 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.08676800 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08621005 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | 0.03245715 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.02300373 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.00920261 |
| 114 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.00505316 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.00183418 |
| 116 | Lysosome_Homo sapiens_hsa04142 | -0.1529565 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1446011 |
| 118 | Focal adhesion_Homo sapiens_hsa04510 | -0.1410646 |
| 119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1239068 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1125368 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1056621 |
| 122 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0814947 |
| 123 | Mineral absorption_Homo sapiens_hsa04978 | -0.0761080 |
| 124 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0731838 |
| 125 | Malaria_Homo sapiens_hsa05144 | -0.0692043 |
| 126 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0664070 |
| 127 | Hepatitis C_Homo sapiens_hsa05160 | -0.0637284 |
| 128 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0356229 |
| 129 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0289186 |

